Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Upper limb SMI for sarcopenia diagnosis in liver cirrhosis ; Скелетно-мышечный индекс верхних конечностей для диагностики саркопении при циррозе печени

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      REMEDIUM GROUP Ltd.
    • الموضوع:
      2024
    • Collection:
      Medical Council (E-Journal) / Медицинский Совет
    • نبذة مختصرة :
      Introduction. The muscle mass in sarcopenia is assessed in patients with liver cirrhosis (LC) using skeletal muscle indices (SMI) measured by dual-energy X-ray absorptiometry (DXA), the results of which are distorted due to lower limb edema. This requires the development of upper limb SMI (UL SMI) to ensure more accurate assessment of muscle mass in patients with LC and ascitice-dematous syndrome.Aim. To compare the diagnostic accuracy of standard MSI and UL SMI, and develop criteria for the reference range of UL SMI in patients with decompensated LC of various origin and sarcopenia, taking into account the lower limb edema in comparable age groups.Materials and methods. A prospective cohort study was conducted. The treatment group included patients with decompensated LC and lower limb edema of various origin; the control group included healthy volunteers matched to patients by gender and age to determine the diagnostic accuracy of the technique and calculate the criteria for the reference ranges in UP SMI. All patients underwent measurements of muscle mass by DXA.Results. A total of 59 patients were examined: 39 patients with LC and 20 healthy volunteers. Based on the results of the ROC analysis, it was determined that the cut-off values for UL SMI are 1.91 kg/m2 for men (sensitivity = 62.5%, specificity = 85.71%) and 1.47 kg/m2 for women (sensitivity = 86.96%, specificity = 69.23%) as compared to the cut-off values for the standard SMI of 7.78 kg/m2 for men (sensitivity = 75% and specificity = 57.14%), and SMI of 6.05 kg/m2 for women (sensitivity = 56.52% and specificity = 69.23%). UL SMI is a more accurate marker of sarcopenia in patients with LC and lower limb edema than the standard SMI.Conclusion. The advantages of UL SMI over classical SMI for sarcopenia diagnosis in patients with cirrhosis and lower extremity edema were demonstrated. The UL SMI criteria for the reference range in patients with decompensated LC and sarcopenia were developed. ; Введение. Для оценки мышечной массы при саркопении у пациентов ...
    • File Description:
      application/pdf
    • Relation:
      https://www.med-sovet.pro/jour/article/view/8579/7534; Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet Lond Engl. 2021;398(10308):1359–7136. https://doi.org/10.1016/S0140-6736(21)01374-X.; GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245–266. https://doi.org/10.1016/S2468-1253(19)30349-8.; Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169.; Tuo S, Yeo YH, Chang R, Wen Z, Ran Q, Yang L et al. Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. Clin Nutr Edinb Scotl. 2024;43(1):84–94. https://doi.org/10.1016/j.clnu.2023.11.008.; Khoury BE, Khazaka S, Chalhoub N, Habib FA, Saba L, Sarkis Y et al. Myosteatosis and Frailty Factors associated with the occurrence of Complications in Cirrhotic patients: MYOFACC study. Ann Clin Gastroenterol Hepatol. 2023;7(1):19–27. https://doi.org/10.29328/journal.acgh.1001041.; Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y et al. Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. J Hepatol. 2022;76(3):588–599. https://doi.org/10.1016/j.jhep.2021.11.006.; Fox R, Stenning K, Slee A, Macnaughtan J, Davies N. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies. Anal Biochem. 2022;647:114581. https://doi.org/10.1016/j.ab.2022.114581.; Островская АС, Маевская МВ. Саркопения и мальнутриция у пациентов с заболеваниями печени. Медицинский совет. 2023;17(18):35–42. https://doi.org/10.21518/ms2023-374.; Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Orlandini A et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Lond Engl. 2015;386(9990):266–273. https://doi.org/10.1016/S0140-6736(14)62000-6.; Schaap LA, van Schoor NM, Lips P, Visser M. Associations of Sarcopenia Definitions, and Their Components, With the Incidence of Recurrent Falling and Fractures: The Longitudinal Aging Study Amsterdam. J Gerontol A Biol Sci Med Sci. 2018;73(9):1199–1204. https://doi.org/10.1093/gerona/glx245.; Hu F-J, Liu H, Liu X-L, Jia S-L, Hou L-S, Xia X et al. Mid-Upper Arm Circumference as an Alternative Screening Instrument to Appendicular Skeletal Muscle Mass Index for Diagnosing Sarcopenia. Clin Interv Aging. 2021;16:1095–1104. https://doi.org/10.2147/CIA.S311081.; Bozic D, Grgurevic I, Mamic B, Capkun V, Bilandzic-Ivisic J, Ivanovic T et al. Detection of Sarcopenia in Patients with Liver Cirrhosis Using the Bioelectrical Impedance Analysis. Nutrients. 2023;15(15):3335. https://doi.org/10.3390/nu15153335.; Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatol Baltim Md. 2021;74(3):1611–1644. https://doi.org/10.1002/hep.32049.; Kamimura H, Sato T, Natsui K, Kobayashi T, Yoshida T, Kamimura K et al. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge. Int J Mol Sci. 2021;22(3):1425. https://doi.org/10.3390/ijms22031425.; Kallwitz ER. Sarcopenia and liver transplant: The relevance of too little muscle mass. World J Gastroenterol WJG. 2015;21(39):10982–10993. https://doi.org/10.3748/wjg.v21.i39.10982.; Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography. Nutr Burbank Los Angel Cty Calif. 2019;61:93–98. https://doi.org/10.1016/j.nut.2018.10.031.; Belarmino G, Gonzalez MC, Sala P, Torrinhas RS, Andraus W, D’Albuquerque LAC et al. Diagnosing Sarcopenia in Male Patients With Cirrhosis by Dual-Energy X-Ray Absorptiometry Estimates of Appendicular Skeletal Muscle Mass. JPEN J Parenter Enteral Nutr. 2018;42(1):24–36. https://doi.org/10.1177/0148607117701400.; Belarmino G, Torrinhas RS, Magalhães NV, Heymsfield SB, Waitzberg DL. New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis. Nutr Burbank Los Angel Cty Calif. 2021;84:111083. https://doi.org/10.1016/j.nut.2020.111083.; Tandon P, Low G, Mourtzakis M, Zenith L, Myers RP, Abraldes JG et al. A Model to Identify Sarcopenia in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016;14(10):1473–1480.e3. https://doi.org/10.1016/j.cgh.2016.04.040.; Гавриленко ДИ, Гавриленко ТЕ, Родина ЕВ. Нарушения питания при хронических заболеваниях печени. Часть 2. Оценка саркопении и коррекция нарушений питания. Вестник Витебского государственного медицинского университета. 2023;22(2):27–34. 2023. Режим доступа: https://elib.vsmu.by/handle/123/24831.; Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. https://doi.org/10.1186/1471-2105-12-77.; Fielding RA, Vellas B, Evans WJ, Bhasin S. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. J Am Med Dir Assoc. 2011;12(4):249–256. https://doi.org/10.1016/j.jamda.2011.01.003.; Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. https://doi.org/10.1016/j.jamda.2013.11.025.; Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748–759. https://doi.org/10.1093/ageing/afu115.; Kashani A, Landaverde C, Medici V, Rossaro L. Fluid retention in cirrhosis: pathophysiology and management. QJM. 2008;101(2):71-85. https://doi.org/10.1093/qjmed/hcm121.; Sinclair M, Hoermann R, Peterson A, Testro A, Angus PW, Hey P et al. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk. Liver Int. 2019;39(6):1089–1097. https://doi.org/10.1111/liv.14071.; Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2021;320(5):729–740. https://doi.org/10.1152/ajpgi.00478.2020.; Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G et al. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol. 2019;25(33):4814–4834. https://doi.org/10.3748/wjg.v25.i33.4814.; Dasarathy S, Hatzoglou M. Hyperammonemia and proteostasis in cirrhosis. Curr Opin Clin Nutr Metab Care. 2018;21(1):30–36. https://doi.org/10.1097/MCO.0000000000000426.; Bunchorntavakul C. Sarcopenia and Frailty in Cirrhosis: Assessment and Management. Med Clin North Am. 2023;107(3):589–604. https://doi.org/10.1016/j.mcna.2022.12.007.; Xia Z, Cholewa J, Zhao Y, Shang HY, Yang YQ, Araújo Pessôa K et al. Targeting Inflammation and Downstream Protein Metabolism in Sarcopenia: A Brief Up-Dated Description of Concurrent Exercise and Leucine-Based Multimodal Intervention. Front Physiol. 2017;8:434. https://doi.org/10.3389/fphys.2017.00434.; Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: abnormalities and implications. J Gastroenterol Hepatol. 2015;30(2):244–251. https://doi.org/10.1111/jgh.12695.; Надинская МЮ, Маевская МВ, Бакулин ИГ, Бессонова ЕН, Буеверов АО, Жаркова МС и др. Диагностическое и прогностическое значение гипераммониемии у пациентов с циррозом печени, печеночной энцефалопатией и саркопенией (соглашение специалистов). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2024;34(1):85–100. https://doi.org/10.22416/1382-4376-2024-34-1-85-100.; Nachit M, De Rudder M, Thissen J, Schakman O, Bouzin C, Horsmans Y et al. Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models. J Cachexia Sarcopenia Muscle. 2021;12(1):144–158. https://doi.org/10.1002/jcsm.12646.; Linge J, Ekstedt M, Dahlqvist Leinhard O. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Rep Innov Hepatol. 2021;3(1):100197. https://doi.org/10.1016/j.jhepr.2020.100197.
    • الرقم المعرف:
      10.21518/ms2024-382
    • الدخول الالكتروني :
      https://www.med-sovet.pro/jour/article/view/8579
      https://doi.org/10.21518/ms2024-382
    • Rights:
      Authors publishing their articles in this journal shall agree to the following:Authors reserve the copyright to the work and grant the journal a license to publish the work for the first time Creative Commons Attribution License (CC BY- NC-ND), which allows other persons to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal.Authors reserve the right to conclude separate contractual arrangements regarding the non-exclusive distribution of the work version in the form published here (for example, posting it in the institute’s repository, publication in a book), with reference to its original publication in this journal.Authors have the right to post work on the Internet (for example, in the institute’s repository or personal website) before and during the process of considering it by this journal, as this can result in a productive discussion and more references to this work. ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License (CC BY- NC-ND), которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию.Авторы имеют право размещать работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу. (См. The Effect of Open Access).
    • الرقم المعرف:
      edsbas.445070C8